The cryopreservation for the in-vitro fertilization market is expected to register a valuation of US$ 461.4 million in 2023. The market is anticipated to rise to US$ 1,264.9 million by 2033. The market is likely to record a CAGR of 10.6% during the forecast period.
Cryopreservation, or freezing and storing biological samples, is an essential technique in the in-vitro fertilization (IVF) field. Here are a few of the driving factors that are fueling the market growth are:
Overall, the market is expected to grow in the coming years as more couples seek fertility treatments and technological advancements continue to improve success rates.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The popularity of cryopreservation for in-vitro fertilization (IVF) is increasing among patients for several reasons:
Overall, the growing popularity of cryopreservation for IVF can be attributed to its improved success rates, flexibility, cost-effectiveness, preservation of fertility, and ethical considerations.
| Attributes | Details |
|---|---|
| Market CAGR (2023 to 2033) | 10.6% |
| Market Valuation (2023) | US$ 461.4 million |
| Market Valuation (2033) | US$ 1,264.9 million |
The increasing demand for IVF treatments, advancements in cryopreservation technology, and rising awareness about the benefits of cryopreservation.
The market has shown steady growth in recent years, and the trend is expected to continue in the coming years. However, it is important to note that the COVID-19 pandemic may have impacted the market performance in 2020 and beyond.
The market is estimated to capture a valuation of US$ 1,264.9 million during the forecast period. Historically, the market registered a valuation of US$ 415.9 million from 2017 to 2022.
Principal Consultant
Cryopreservation for In-vitro Fertilization Market:
| Attributes | Cryopreservation for In-vitro Fertilization Market |
|---|---|
| CAGR (2023 to 2033) | 10.6% |
| Value (2023) | US$ 461.4 million |
| Value (2033) | US$ 1,264.9 million |
| Trends | Growing prevalence of genetic testing and delay in parenthood are driving the market growth. |
| Opportunities | Rising government initiatives, market players, and research & development activities. |
Cell Freezing Media Market:
| Attributes | Cell Freezing Media Market |
|---|---|
| CAGR (2023 to 2033) | 4.2% |
| Value (2023) | US$ 736.62 million |
| Value (2033) | US$ 1,111.53 million |
| Trends | The rising pharmaceutical industry, development of therapies, and availability of advanced products are driving the market. |
| Opportunities | Growing new technologies, research & development activities, and innovation of products are propelling market opportunities. |
Cryopreservation Equipment Market:
| Attributes | Cryopreservation Equipment Market |
|---|---|
| CAGR (2023 to 2033) | 6.8% |
| Value (2023) | US$ 2.23 billion |
| Value (2033) | US$ 3.36 billion |
| Trends | Innovation of chronic therapies, growing clinical biotechnology companies, and launching advanced freezing equipment drive the market. |
| Opportunities | Surge in investments, key players, government support, and research & development activities are propelling the market. |
In the global market, the product type category that highly influences the market is the cryopreservation media segment. Cryopreservation media are the solutions used to freeze and store biological samples, such as embryos, eggs, and sperm, in IVF procedures. The cryopreservation media is likely to capture a CAGR of 10.5% by 2033.
The cryopreservation media segment is expected to witness significant growth in the coming years. The increasing demand for IVF treatments, rising awareness about the benefits of cryopreservation, and technological advancements in cryopreservation media.
According to Future Market Insights report, the cryopreservation media segment to the increasing use of vitrification as a method of cryopreservation, which requires specialized media. Overall, the cryopreservation media segment is expected to be a key influencer in the global market due to its crucial role in the freezing and storing of biological samples. Historically, cryopreservation media registered a CAGR of 9.2% from 2018 to 2022.
The end-user category that dominates the global cryopreservation for the in-vitro fertilization market is fertility clinics. Fertility clinics are specialized healthcare facilities that offer infertility treatments, including IVF procedures, to couples having difficulty conceiving. The IVF & fertility clinics are expected to capture a CAGR of 9.9% by 2033.
The fertility clinics segment is expected to continue to lead the market share globally. The increasing prevalence of infertility and the availability of advanced fertility treatments in developed countries as key drivers of the segment's growth. Historically, IVF & fertility clinics registered a CAGR of 8.6% from 2018 to 2022.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The United States has been one of the leading markets for cryopreservation in-vitro fertilization (IVF) services. According to a report by Future Market Insights, the United States is likely to thrive at a CAGR of 11.2% with a valuation of US$ 182.7 million by 2033.
The report attributes the strong performance of the United States market to several factors, including:
Overall, the increasing demand for fertility treatments and the availability of advanced healthcare infrastructure and technologies driving the market in the United States. Historically, the United States cryopreservation for the in-vitro fertilization market secured a CAGR of 9.9% between 2018 and 2022.
Germany has been a significant market for cryopreservation in-vitro fertilization (IVF) services. According to a report by Future Market Insights, Germany is expected to be one of the fast-growing markets in Europe during the forecast period. Germany is securing a CAGR of 11.6% with a valuation of US$ 54.8 million by 2033.
Germany is known for its advanced healthcare infrastructure and is one of the leading countries in Europe regarding reproductive medicine. It has led to a thriving cryopreservation market for in-vitro fertilization (IVF) in Germany.
Cryopreservation is freezing and storing eggs, sperm, or embryos for later use in IVF. This technology has revolutionized the field of reproductive medicine, allowing couples to conceive even after years of infertility.
Germany has some of the most advanced IVF clinics in Europe, offering cutting-edge cryopreservation technologies. These clinics use state-of-the-art equipment and techniques to freeze and store eggs, sperm, and embryos, which can be used for IVF later.
Germany has a well-established legal framework that regulates IVF and cryopreservation. It gives patients confidence that the highest ethical and safety standards handle frozen eggs, sperm, or embryos.
Overall, Germany is expected to continue to be driven by the increasing demand for fertility treatments and supportive government policies. Historically, Germany cryopreservation for in-vitro fertilization market secured a CAGR of 10.1% between 2018 and 2022.
The United Kingdom is significantly growing the global market by capturing a CAGR of 11.0% with a valuation of US$ 37 million by 2033. Growing healthcare infrastructure and strong research and development activities drive the United States cryopreservation for in-vitro fertilization market. While marketers play a role in promoting the benefits of cryopreservation, they are not the primary drivers of the market.
IVF clinics and healthcare providers in the United Kingdom are at the forefront of promoting cryopreservation as a viable option for couples who face fertility issues. These clinics offer advanced cryopreservation techniques and equipment, which have greatly improved the success rates of IVF procedures.
The United Kingdom has a strong research and development culture, with many universities and research institutions working on developing new technologies and techniques in the field of reproductive medicine. It has helped to advance the cryopreservation field, making it more accessible and effective for couples seeking IVF treatment.
While marketers may promote the benefits of cryopreservation through various channels, such as social media and advertising campaigns. The decision to undergo IVF treatment and cryopreservation ultimately lies with the patients and their healthcare providers.
The success of the cryopreservation market in the United Kingdom is primarily driven by the availability of advanced healthcare infrastructure and a supportive legal framework. Historically, the United States secured a CAGR of 9.7% between 2018 and 2022.
The cryopreservation for in-vitro fertilization (IVF) market is highly competitive and fragmented, with several players operating globally. The prominent players are focusing on providing services per patients' requirements through their research and development activities. Moreover, the market players adopt strategic plans for uplifting the market through partnerships, mergers, and acquisitions.
Other Prominent Players in the Cryopreservation for in-vitro fertilization Market are:
Recent Developments in the Global Cryopreservation for In-vitro Fertilization Market are:
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ billion for Value |
| Key Countries Covered | United States, Canada, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Türkiye, Northern Africa, and South Africa |
| Key Segments Covered | Product, End User, Region |
| Key Companies Profiled | Thermo Fisher Scientific Inc.; Merck KGaA; VWR International, LLC; Avantor, Inc.; Charter Medical Ltd.; BioLife Solutions, Inc.; Cesca Therapeutics Inc.; Worthington Industries, Inc.; Taylor-Wharton International LLC |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
In 2023, the global demand for cryopreservation for IVF could generate US$ 461.4 million in revenue.
The global adoption of IVF cryopreservation is poised to witness a 10.6% CAGR through 2033.
The cryopreservation media segment garners higher revenue and is poised to have a 10.5% CAGR until 2033.
The regional market is expected to reach US$ 182.7 million by 2033 following an 11.2% CAGR till then.
The overall demand in Europe is poised to be driven by Germany with an 11.6% CAGR through 2033.
1. Executive Summary | Cryopreservation for In-vitro Fertilization (IVF) Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. Cryopreservation Media 5.3.2. Cryopreservation Storage Devices 5.3.2.1. Dewars 5.3.2.2. Cryogenic Liquid Cylinders 5.3.2.3. Cryogenic Storage Tanks 5.3.2.4. Storage Container 5.3.3. Consumables & Accessories 5.3.3.1. Vitrification Carriers 5.3.3.2. Sperm Straws 5.3.3.3. Saw Freeze Straws 5.3.3.4. Cryovials 5.3.4. Cryo-Shipping 5.3.4.1. Dry Shipper Container 5.3.4.2. Clinical Pack Over Wrap 5.3.4.3. Cryogenic Labels 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033 6.3.1. Oocycte Cryopreservation 6.3.2. Sperm Cryopreservation 6.3.3. Embryo Cryopreservation 6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033 7.3.1. Biobanks 7.3.2. IVF & Fertility Clinics 7.3.3. Research & Academic Institutes 7.3.4. Cryo-shipping/couriers 7.3.5. Cryo Monitoring /Inventory Management 7.4. Y-o-Y Growth Trend Analysis By End User , 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. South Asia 8.3.5. East Asia 8.3.6. Oceania 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. The USA 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Application 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Application 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Application 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Application 10.3.4. By End User 10.4. Key Takeaways 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. United Kingdom 11.2.1.2. Spain 11.2.1.3. Germany 11.2.1.4. Italy 11.2.1.5. France 11.2.1.6. Rest of Europe 11.2.2. By Product Type 11.2.3. By Application 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Application 11.3.4. By End User 11.4. Key Takeaways 12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Malaysia 12.2.1.3. Indonesia 12.2.1.4. Thailand 12.2.1.5. Rest of South Asia 12.2.2. By Product Type 12.2.3. By Application 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Application 12.3.4. By End User 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Product Type 13.2.3. By Application 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Application 13.3.4. By End User 13.4. Key Takeaways 14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. Australia 14.2.1.2. New Zealand 14.2.2. By Product Type 14.2.3. By Application 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Application 14.3.4. By End User 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. South Africa 15.2.1.2. GCC Countries 15.2.1.3. Rest of Middle East and Africa 15.2.2. By Product Type 15.2.3. By Application 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Application 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Product Type 16.1.2.2. By Application 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Product Type 16.2.2.2. By Application 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Product Type 16.3.2.2. By Application 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Product Type 16.4.2.2. By Application 16.4.2.3. By End User 16.5. United Kingdom 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Product Type 16.5.2.2. By Application 16.5.2.3. By End User 16.6. Spain 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Product Type 16.6.2.2. By Application 16.6.2.3. By End User 16.7. Germany 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Product Type 16.7.2.2. By Application 16.7.2.3. By End User 16.8. Italy 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Product Type 16.8.2.2. By Application 16.8.2.3. By End User 16.9. France 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Product Type 16.9.2.2. By Application 16.9.2.3. By End User 16.10. India 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Product Type 16.10.2.2. By Application 16.10.2.3. By End User 16.11. Malaysia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Product Type 16.11.2.2. By Application 16.11.2.3. By End User 16.12. Indonesia 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Product Type 16.12.2.2. By Application 16.12.2.3. By End User 16.13. Thailand 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Product Type 16.13.2.2. By Application 16.13.2.3. By End User 16.14. China 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Product Type 16.14.2.2. By Application 16.14.2.3. By End User 16.15. Japan 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Product Type 16.15.2.2. By Application 16.15.2.3. By End User 16.16. South Korea 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Product Type 16.16.2.2. By Application 16.16.2.3. By End User 16.17. Australia 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Product Type 16.17.2.2. By Application 16.17.2.3. By End User 16.18. New Zealand 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Product Type 16.18.2.2. By Application 16.18.2.3. By End User 16.19. South Africa 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Product Type 16.19.2.2. By Application 16.19.2.3. By End User 16.20. GCC Countries 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Product Type 16.20.2.2. By Application 16.20.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product Type 17.3.3. By Application 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Thermo Fisher Scientific Inc. 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Millipore Sigma 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. FUJIFILM Irvine Scientific 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Vitrolife AB 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. KITAZATO CORPORATION 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Brooks Life Sciences 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Corning Inc. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Worthington Industries Inc. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Cook Medical LLC 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Bio-Math Tech Ltd 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.11. Cryo Solutions B.V. 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.12. Cryogatt Systems Ltd. 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Cryopreservation for In-vitro Fertilization (IVF) Market
